|
시장보고서
상품코드
1766392
내시경 지혈기구 시장 규모, 점유율, 산업 분석 보고서 : 제품별, 최종 용도별, 지역별 - 시장 예측(2025-2034년)Endoscopic Hemostasis Devices Market Size, Share, & Industry Analysis Report: By Product, By End Use (Hospitals and Outpatient Facilities), and By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 내시경 지혈기구 시장 규모는 2034년까지 29억 5,480만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
내시경 지혈기구는 내시경 시술 중 활발한 소화관 출혈을 제어하기 위해 고안된 최소침습적 기구로 정의됩니다. 정밀 기반 치료에 대한 수요가 증가함에 따라 이 기기의 관련성이 높아지고 있습니다. 기기의 소형화 및 조작성 향상으로 도달하기 어려운 출혈 부위에 대한 접근이 가능해져 임상 결과가 개선되고 있습니다. 이러한 발전으로 내시경 의사는 환자의 불편함을 줄이고 회복 시간을 단축하는 동시에 보다 정밀한 중재술을 시행할 수 있게 되었습니다. 의료 서비스 제공자들이 시술의 효율성을 높이기 위해 소형, 사용하기 쉬운 의료기기 통합을 전략적 우선순위로 삼고 있으며, 이는 임상 현장에서의 채택을 더욱 촉진하고 있습니다.
클리핑, 응고, 주사 기능을 하나의 시스템에 통합함으로써 다기능 기술이 하나의 기기에 통합되어 성장 기회를 더욱 촉진합니다. 이러한 기능의 통합은 시술 시간을 단축하고 기기 교체 필요성을 최소화하여 중요한 개입 시 워크플로우와 안전성을 향상시킵니다. 또한, 가치 기반 진료 모델로의 전환은 높은 수준의 임상적 효과를 유지하면서 비용 효율성을 개선할 수 있는 다용도 도구의 채택을 촉진하고 있습니다. 이러한 추세는 내시경 출혈 관리의 전망을 재정의하고, 현대 소화기 진료의 진화하는 니즈와 기술 혁신을 일치시키고 있습니다.
내시경 지혈기구 시장 보고서 하이라이트
제품별로는 결찰 클립이 임상적 효과, 사용 편의성, 소화관 출혈 관리에 대한 폭넓은 채택으로 2024년 시장을 주도했습니다.
최종 용도별로는 최소침습적 기술과 비용 효율적인 헬스케어 솔루션으로의 전환으로 외래 환자 분야가 가장 빠르게 성장할 것으로 예상됩니다.
2024년에는 북미가 가장 큰 매출 점유율을 차지했으며, 첨단 의료 시스템, 최소침습적 시술의 높은 채택률, 주요 장비 제조업체의 지원을 받고 있습니다.
아시아태평양의 내시경 지혈기구 시장은 소화기 질환의 증가, 내시경 치료에 대한 인식 개선, 의료 인프라 개선에 힘입어 빠르게 성장할 것으로 예상됩니다.
목차
제1장 소개
제2장 주요 요약
제3장 조사 방법
제4장 세계의 내시경 지혈기구 시장 인사이트
- 시장 현황
- 내시경 지혈기구 시장 역학
- 성장 촉진요인과 기회
- 소화기질환 유병률 상승
- 진보와 제품 혁신 증대
- 성장 억제요인과 과제
- 디바이스의 고비용
- 성장 촉진요인과 기회
- PESTEL 분석
- 내시경 지혈기구 시장 동향
- 밸류체인 분석
제5장 세계의 내시경 지혈기구 시장 : 제품별
- 주요 조사 결과
- 소개
- 결찰 클립
- 결찰 밴드
- 주사침
- 지혈 스프레이
- 서멀 프로브
- 아르곤 플라즈마 응고법(APC)
- 고주파 절제(RFA)
제6장 세계의 내시경 지혈기구 시장 : 최종 용도별
- 주요 조사 결과
- 소개
- 병원
- 외래 시설
제7장 세계의 내시경 지혈기구 시장 : 지역별
- 주요 조사 결과
- 소개
- 내시경 지혈기구 시장 분석 : 지역, 2020-2034년
- 북미
- 북미 : 제품별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별, 2020-2034년
- 유럽 : 최종 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제8장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제9장 기업 개요
- Ambu A/S
- Boston Scientific Corporation
- CONMED Corporation.
- Cook Medical Inc.
- FUJIFILM India Private Limited
- HOYA Corporation.(PENTAX Medical)
- Johnson & Johnson
- KARL STORZ
- Medtronic
- MICRO-TECH(Nanjing) Co., Ltd.
- Olympus America Inc.
- Richard Wolf GmbH.
- Smith+Nephew
- STERIS
- Stryker
The endoscopic hemostasis devices market size is expected to reach USD 2,954.80 million by 2034, according to a new study by Polaris Market Research. The report "Endoscopic Hemostasis Devices Market Size, Share, & Industry Analysis Report: By Product, By End Use (Hospitals and Outpatient Facilities), and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Endoscopic hemostasis devices are defined as minimally invasive instruments designed to control active gastrointestinal bleeding during endoscopies procedures. The devices are witnessing increased relevance amid the growing demand for precision-based therapeutics. The transition toward device miniaturization and improved maneuverability allows for greater access to difficult-to-reach bleeding sites with improved clinical outcomes. These advancements are allowing endoscopists to perform more targeted interventions with reduced patient discomfort and faster recovery times. The integration of compact, user-friendly medical devices has become a strategic priority as healthcare providers seek to improve procedural efficiency, further reinforcing their adoption across clinical settings.
The integration of multifunctional technologies within single devices, combining clipping, coagulation, and injection capabilities into one system, further propels growth opportunities. This convergence of functionalities reduces procedural time and also minimizes the need for device exchange, improving workflow and safety during critical interventions. Additionally, the shift toward value-based care models is encouraging the adoption of versatile tools that can improve cost-efficiency while maintaining high standards of clinical effectiveness. Together, these trends are redefining the landscape of endoscopic bleeding management, aligning innovation with the evolving needs of the modern gastroenterological practice.
Endoscopic Hemostasis Devices Market Report Highlights
In terms of product, the ligation clips segment led the market in 2024, favored for their clinical efficacy, ease of use, and broad adoption in gastrointestinal bleeding management.
Based on end use, the outpatient segment is anticipated to grow the fastest, driven by the shift toward minimally invasive techniques and cost-efficient healthcare solutions.
In 2024, North America held the largest revenue share, supported by advanced healthcare systems, high adoption of minimally invasive procedures, and leading device manufacturers.
The Asia Pacific endoscopic hemostasis devices market is expected to grow the fastest, propelled by increasing GI disorder prevalence, greater awareness of endoscopic treatments, and improving healthcare infrastructure.
A few global key market players include Ambu A/S; Boston Scientific Corporation; CONMED Corporation; Cook Medical Inc.; FUJIFILM India Private Limited; HOYA Corporation (PENTAX Medical); Johnson & Johnson; KARL STORZ; Medtronic; MICRO-TECH (Nanjing) Co., Ltd.; Olympus America Inc.; Richard Wolf GmbH; Smith+Nephew; STERIS; and Stryker.
Polaris Market Research has segmented the endoscopic hemostasis devices market report on the basis of product, end use, and region:
By Product Outlook (Revenue, USD Million, 2020-2034)
Ligation Clips
Ligation Bands
Hemorrhoidal
Esophageal
Injection Needles
Hemostatic Spray
Thermal Probes
Contact Probes
Noncontact Probes
Argon Plasma Coagulation (APC)
Radiofrequency Ablation (RFA)
By End Use Outlook (Revenue, USD Million, 2020-2034)
Hospitals
Outpatient Facilities
By Regional Outlook (Revenue, USD Million, 2020-2034)
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Endoscopic Hemostasis Devices Market Insights
- 4.1. Endoscopic Hemostasis Devices Market - Market Snapshot
- 4.2. Endoscopic Hemostasis Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Gastrointestinal Disorders
- 4.2.1.2. Increasing Advancements and Product Innovation
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost of Devices
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Endoscopic Hemostasis Devices Market Trends
- 4.6. Value Chain Analysis
5. Global Endoscopic Hemostasis Devices Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 5.3. Ligation Clips
- 5.3.1. Global Endoscopic Hemostasis Devices Market, by Ligation Clips, by Region, 2020-2034 (USD Million)
- 5.4. Ligation Bands
- 5.4.1. Global Endoscopic Hemostasis Devices Market, by Ligation Bands, by Region, 2020-2034 (USD Million)
- 5.4.2. Hemorrhoidal
- 5.4.2.1. Global Endoscopic Hemostasis Devices Market, by Hemorrhoidal, by Region, 2020-2034 (USD Million)
- 5.4.3. Esophageal
- 5.4.3.1. Global Endoscopic Hemostasis Devices Market, by Esophageal, by Region, 2020-2034 (USD Million)
- 5.5. Injection Needles
- 5.5.1. Global Endoscopic Hemostasis Devices Market, by Injection Needles, by Region, 2020-2034 (USD Million)
- 5.6. Hemostatic Spray
- 5.6.1. Global Endoscopic Hemostasis Devices Market, by Hemostatic Spray, by Region, 2020-2034 (USD Million)
- 5.7. Thermal Probes
- 5.7.1. Global Endoscopic Hemostasis Devices Market, by Thermal Probes, by Region, 2020-2034 (USD Million)
- 5.7.2. Contact Probes
- 5.7.2.1. Global Endoscopic Hemostasis Devices Market, by Contact Probes, by Region, 2020-2034 (USD Million)
- 5.7.3. Noncontact Probes
- 5.7.3.1. Global Endoscopic Hemostasis Devices Market, by Noncontact Probes, by Region, 2020-2034 (USD Million)
- 5.8. Argon Plasma Coagulation (APC)
- 5.8.1. Global Endoscopic Hemostasis Devices Market, by Argon Plasma Coagulation (APC), by Region, 2020-2034 (USD Million)
- 5.9. Radiofrequency Ablation (RFA)
- 5.9.1. Global Endoscopic Hemostasis Devices Market, by Radiofrequency Ablation (RFA), by Region, 2020-2034 (USD Million)
6. Global Endoscopic Hemostasis Devices Market, by End Use
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 6.3. Hospitals
- 6.3.1. Global Endoscopic Hemostasis Devices Market, by Hospitals, by Region, 2020-2034 (USD Million)
- 6.4. Outpatient Facilities
- 6.4.1. Global Endoscopic Hemostasis Devices Market, by Outpatient Facilities, by Region, 2020-2034 (USD Million)
7. Global Endoscopic Hemostasis Devices Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Endoscopic Hemostasis Devices Market Assessment, By Geography, 2020-2034 (USD Million)
- 7.3. Endoscopic Hemostasis Devices Market - North America
- 7.3.1. North America: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.3.2. North America: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.3.3. Endoscopic Hemostasis Devices Market - US
- 7.3.3.1. US: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.3.3.2. US: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.3.4. Endoscopic Hemostasis Devices Market - Canada
- 7.3.4.1. Canada: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.3.4.2. Canada: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4. Endoscopic Hemostasis Devices Market - Europe
- 7.4.1. Europe: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.2. Europe: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.3. Endoscopic Hemostasis Devices Market - UK
- 7.4.3.1. UK: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.3.2. UK: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.4. Endoscopic Hemostasis Devices Market - France
- 7.4.4.1. France: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.4.2. France: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.5. Endoscopic Hemostasis Devices Market - Germany
- 7.4.5.1. Germany: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.5.2. Germany: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.6. Endoscopic Hemostasis Devices Market - Italy
- 7.4.6.1. Italy: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.6.2. Italy: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.7. Endoscopic Hemostasis Devices Market - Spain
- 7.4.7.1. Spain: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.7.2. Spain: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.8. Endoscopic Hemostasis Devices Market - Netherlands
- 7.4.8.1. Netherlands: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.8.2. Netherlands: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.9. Endoscopic Hemostasis Devices Market - Russia
- 7.4.9.1. Russia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.9.2. Russia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.4.10. Endoscopic Hemostasis Devices Market - Rest of Europe
- 7.4.10.1. Rest of Europe: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.4.10.2. Rest of Europe: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5. Endoscopic Hemostasis Devices Market - Asia Pacific
- 7.5.1. Asia Pacific: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.2. Asia Pacific: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.3. Endoscopic Hemostasis Devices Market - China
- 7.5.3.1. China: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.3.2. China: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.4. Endoscopic Hemostasis Devices Market - India
- 7.5.4.1. India: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.4.2. India: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.5. Endoscopic Hemostasis Devices Market - Malaysia
- 7.5.5.1. Malaysia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.5.2. Malaysia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.6. Endoscopic Hemostasis Devices Market - Japan
- 7.5.6.1. Japan: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.6.2. Japan: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.7. Endoscopic Hemostasis Devices Market - Indonesia
- 7.5.7.1. Indonesia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.7.2. Indonesia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.8. Endoscopic Hemostasis Devices Market - South Korea
- 7.5.8.1. South Korea: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.8.2. South Korea: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.9. Endoscopic Hemostasis Devices Market - Australia
- 7.5.9.1. Australia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.9.2. Australia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.5.10. Endoscopic Hemostasis Devices Market - Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.5.10.2. Rest of Asia Pacific: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.6. Endoscopic Hemostasis Devices Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.2. Middle East & Africa: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.6.3. Endoscopic Hemostasis Devices Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.3.2. Saudi Arabia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.6.4. Endoscopic Hemostasis Devices Market - UAE
- 7.6.4.1. UAE: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.4.2. UAE: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.6.5. Endoscopic Hemostasis Devices Market - Israel
- 7.6.5.1. Israel: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.5.2. Israel: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.6.6. Endoscopic Hemostasis Devices Market - South Africa
- 7.6.6.1. South Africa: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.6.2. South Africa: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.6.7. Endoscopic Hemostasis Devices Market - Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.6.7.2. Rest of Middle East & Africa: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.7. Endoscopic Hemostasis Devices Market - Latin America
- 7.7.1. Latin America: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.7.2. Latin America: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.7.3. Endoscopic Hemostasis Devices Market - Mexico
- 7.7.3.1. Mexico: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.7.3.2. Mexico: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.7.4. Endoscopic Hemostasis Devices Market - Brazil
- 7.7.4.1. Brazil: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.7.4.2. Brazil: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.7.5. Endoscopic Hemostasis Devices Market - Argentina
- 7.7.5.1. Argentina: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.7.5.2. Argentina: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
- 7.7.6. Endoscopic Hemostasis Devices Market - Rest of Latin America
- 7.7.6.1. Rest of Latin America: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
- 7.7.6.2. Rest of Latin America: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Ambu A/S
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Boston Scientific Corporation
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. CONMED Corporation.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Cook Medical Inc.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. FUJIFILM India Private Limited
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. HOYA Corporation. (PENTAX Medical)
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Johnson & Johnson
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. KARL STORZ
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Medtronic
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. MICRO-TECH (Nanjing) Co., Ltd.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Olympus America Inc.
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Richard Wolf GmbH.
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Smith+Nephew
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. STERIS
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
- 9.15. Stryker
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
